stem cell Options
CALEC is patent-pending. Jurkunas and Dana have fiscal curiosity in OcuCell, a corporation producing residing ophthalmic cell-primarily based therapies for dealing with eye illness. Armant serves around the scientific advisory board for OcuCell.bone regeneration, skin treatment and therapies to beat most cancers and stopping arteries from turning i